Specifically, upon treatment of the hardly tractable PBT003 cells with AD carrying the siRNA was directed against the signal transducer and activator of transcription 3 (STAT3), which is a key player protein in glioma-initiating cells, thought to be responsible for glioblastoma induction, progression and recurrence. This evidence concerns the gene STAT3 and Alzheimer disease.